Can SARS-CoV-2 infection lead to neurodegeneration and Parkinson's disease?

L Krey, MK Huber, GU Höglinger, F Wegner - Brain Sciences, 2021 - mdpi.com
The SARS-CoV-2 pandemic has affected the daily life of the worldwide population since
2020. Links between the newly discovered viral infection and the pathogenesis of …

The European Academy of Neurology Brain Health Strategy: one brain, one life, one approach

CLA Bassetti, M Endres, A Sander… - European journal of …, 2022 - Wiley Online Library
Background and purpose Brain health is essential for health, well‐being, productivity and
creativity across the entire life. Its definition goes beyond the absence of disease embracing …

[图书][B] Optimizing brain health across the life course: WHO position paper

World Health Organization - 2022 - books.google.com
Page 1 Optimizing brain health across the life course: WHO position paper World Health
Organization Page 2 World Health Organization Optimizing brain health across the life course …

Telemedicine in headache medicine: a narrative review

J Robblee - Current Pain and Headache Reports, 2023 - Springer
Abstract Purpose of Review The purpose of the study is to review and discuss the use of
telemedicine in headache medicine. Recent Findings Before the COVID-19 pandemic, the …

Global survey on disruption and mitigation of neurological services during COVID-19: the perspective of global international neurological patients and scientific …

CC Triki, M Leonardi, SZ Mallouli, M Cacciatore… - Journal of …, 2022 - Springer
Background The COVID-19 pandemic outbreak has dramatically disrupted healthcare
systems. Two rapid WHO pulse surveys studied disruptions in mental health services, but …

Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case …

M Habek, GJ Brecl, VB Kes, D Rogić, B Barun… - Journal of …, 2021 - Elsevier
Aim To determine the influence of high-efficacy disease modifying therapy (DMT) on the
development of IgG SARS-CoV-2 antibody response in COVID-19 convalescent people with …

Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in COVID-19 patients: a narrative review

T Takizawa, K Ihara, S Uno, S Ohtani… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Migraine pharmacological therapies targeting calcitonin gene-related peptide
(CGRP), including monoclonal antibodies and gepants, have shown clinical effect and …

COVID-19 and integrated multidisciplinary care model in Parkinson's disease: literature review & future perspectives

SM Fereshtehnejad, M Rodríguez-Violante… - Behavioral …, 2022 - mdpi.com
Clinical diversity and multi-systemic manifestations of Parkinson's disease (PD) necessitate
the involvement of several healthcare professionals from different disciplines for optimal …

The indirect impact of COVID-19 on major clinical outcomes of people with Parkinson's disease or parkinsonism: a cohort study

L Vignatelli, F Baccari, LMB Belotti, C Zenesini… - Frontiers in …, 2022 - frontiersin.org
Background The indirect impact of the COVID-19 epidemic on major clinical outcomes of
people with Parkinson's disease (PD) or other parkinsonism is unknown. Objectives The …

Feasibility of telemedical HINTS (head impulse-nystagmus-test of skew) evaluation in patients with acute dizziness or vertigo in the emergency department of primary …

R von Martial, C Leinweber, N Hubert… - Frontiers in …, 2022 - frontiersin.org
Background Acute dizziness, vertigo and imbalance are common symptoms in emergency
departments. Stroke needs to be distinguished from vestibular diseases. A battery of three …